Institutional shares held 28.7 Million
8.2K calls
2.3K puts
Total value of holdings $200M
$57K calls
$16K puts
Market Cap $219M
31,368,500 Shares Out.
Institutional ownership 91.44%
# of Institutions 112


Latest Institutional Activity in TRDA

Top Purchases

Q2 2025
Versant Capital Management, Inc Shares Held: 1.46K ($10.2K)
Q1 2025
Wellington Management Group LLP Shares Held: 1.05M ($7.34M)
Q1 2025
Renaissance Technologies LLC Shares Held: 328K ($2.29M)
Q1 2025
Vanguard Group Inc Shares Held: 1.58M ($11M)
Q1 2025
Dimensional Fund Advisors LP Shares Held: 327K ($2.28M)

Top Sells

Q1 2025
Goldman Sachs Group Inc Shares Held: 92.5K ($645K)
Q1 2025
Price T Rowe Associates Inc Shares Held: 2.74M ($19.1M)
Q1 2025
Arrowstreet Capital, Limited Partnership Shares Held: 124K ($864K)
Q1 2025
Connor, Clark & Lunn Investment Management Ltd. Shares Held: 11.6K ($80.5K)
Q1 2025
Citadel Advisors LLC Shares Held: 16.5K ($115K)

About TRDA

Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in preclinical trail for the treatment of Duchenne muscular dystrophy and myotonic dystrophy type 1. It also engages in the development of EEV-PMO-CAG for the treatment of myotonic dystrophy type 1. The company was formerly known as CycloPorters, Inc. and changed its name to Entrada Therapeutics, Inc. in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.


Insider Transactions at TRDA

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
323K Shares
From 6 Insiders
Grant, award, or other acquisition 280K shares
Exercise of conversion of derivative security 43.1K shares
Sell / Disposition
482K Shares
From 12 Insiders
Payment of exercise price or tax liability 47.8K shares
Open market or private sale 435K shares

Track Institutional and Insider Activities on TRDA

Follow Entrada Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TRDA shares.

Notify only if

Insider Trading

Get notified when an Entrada Therapeutics, Inc. insider buys or sells TRDA shares.

Notify only if

News

Receive news related to Entrada Therapeutics, Inc.

Track Activities on TRDA